• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15.我们准备好申请报销了吗？健康技术评估相关真实世界证据的发展综述：第15部分。
J Comp Eff Res. 2024 May;13(5):e240033. doi: 10.57264/cer-2024-0033. Epub 2024 Mar 28.
2
RWE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 16.真实世界研究是否已准备好报销？与卫生技术评估相关的真实世界证据发展综述：第 16 部分。
J Comp Eff Res. 2024 Aug;13(8):e240095. doi: 10.57264/cer-2024-0095. Epub 2024 Jul 5.
3
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 14.我们是否已经准备好进行报销了？真实世界证据在卫生技术评估方面的发展综述：第 14 部分。
J Comp Eff Res. 2024 Jan;13(1):e230189. doi: 10.57264/cer-2023-0189. Epub 2024 Jan 4.
4
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 7.我们是否已准备好进行报销？与健康技术评估相关的真实世界证据的最新进展：第 7 部分。
J Comp Eff Res. 2022 Jul;11(10):699-701. doi: 10.2217/cer-2022-0071. Epub 2022 May 4.
5
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10.我们是否已经准备好进行报销了？关于与健康技术评估相关的真实世界证据的最新进展综述：第 10 部分。
J Comp Eff Res. 2023 Jan;12(1):e220194. doi: 10.2217/cer-2022-0194. Epub 2022 Dec 1.
6
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 6.我们准备好申请报销了吗？健康技术评估相关真实世界证据的进展综述：第6部分。
J Comp Eff Res. 2022 May;11(7):473-475. doi: 10.2217/cer-2022-0043. Epub 2022 Mar 9.
7
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13.我们准备好申请报销了吗？关于健康技术评估的真实世界证据进展综述：第13部分。
J Comp Eff Res. 2023 Nov;12(11):e230141. doi: 10.57264/cer-2023-0141. Epub 2023 Sep 15.
8
R WE ready for reimbursement? A round up of developments in real-world evidence relating to HTA: part 5.我们是否已经准备好进行报销了？与 HTA 相关的真实世界证据的最新进展综述：第 5 部分。
J Comp Eff Res. 2022 Mar;11(4):213-215. doi: 10.2217/cer-2021-0302. Epub 2022 Jan 6.
9
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 9.我们是否已经准备好进行报销了？关于与健康技术评估相关的真实世界证据的最新进展综述：第 9 部分。
J Comp Eff Res. 2022 Nov;11(16):1147-1149. doi: 10.2217/cer-2022-0145. Epub 2022 Aug 23.
10
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 8.我们是否已经准备好进行报销了？现实世界证据在卫生技术评估方面的最新进展综述：第 8 部分。
J Comp Eff Res. 2022 Sep;11(13):915-917. doi: 10.2217/cer-2022-0103. Epub 2022 Jun 15.

引用本文的文献

1
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 19.我们准备好申请报销了吗？与卫生技术评估相关的真实世界证据发展综述：第19部分。
J Comp Eff Res. 2025 Jul;14(7):e250063. doi: 10.57264/cer-2025-0063. Epub 2025 May 12.
2
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18.我们准备好申请报销了吗？与卫生技术评估相关的真实世界证据进展综述：第18部分。
J Comp Eff Res. 2025 Apr;14(4):e250014. doi: 10.57264/cer-2025-0014. Epub 2025 Feb 18.
3
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 17.我们准备好申请报销了吗？与卫生技术评估相关的真实世界证据进展综述：第17部分。
J Comp Eff Res. 2025 Jan;14(1):e240212. doi: 10.57264/cer-2024-0212. Epub 2024 Nov 27.

本文引用的文献

1
Process guide for inferential studies using healthcare data from routine clinical practice to evaluate causal effects of drugs (PRINCIPLED): considerations from the FDA Sentinel Innovation Center.利用常规临床实践中的医疗数据评估药物因果效应的推断性研究流程指南（PRINCIPLED）：来自美国食品药品监督管理局哨兵创新中心的考量
BMJ. 2024 Feb 12;384:e076460. doi: 10.1136/bmj-2023-076460.
2
Real-World Database Studies in Oncology: A Call for Standards.肿瘤学中的真实世界数据库研究：对标准的呼吁。
J Clin Oncol. 2024 Mar 20;42(9):977-980. doi: 10.1200/JCO.23.02399. Epub 2024 Feb 6.
3
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 14.我们是否已经准备好进行报销了？真实世界证据在卫生技术评估方面的发展综述：第 14 部分。
J Comp Eff Res. 2024 Jan;13(1):e230189. doi: 10.57264/cer-2023-0189. Epub 2024 Jan 4.
4
Emulating Trials and Quantifying Bias: The Convergence of Health Technology Assessment Agency Real-World Evidence Guidance.
Value Health. 2024 Feb;27(2):265-267. doi: 10.1016/j.jval.2023.11.010. Epub 2023 Dec 21.
5
ESMO Guidance for Reporting Oncology real-World evidence (GROW).欧洲肿瘤内科学会（ESMO）肿瘤学真实世界证据报告指南（GROW）
Ann Oncol. 2023 Dec;34(12):1097-1112. doi: 10.1016/j.annonc.2023.10.001. Epub 2023 Oct 15.
6
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 13.我们准备好申请报销了吗？关于健康技术评估的真实世界证据进展综述：第13部分。
J Comp Eff Res. 2023 Nov;12(11):e230141. doi: 10.57264/cer-2023-0141. Epub 2023 Sep 15.
7
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 12.我们是否已经准备好进行报销了？真实世界证据在卫生技术评估方面的发展综述：第 12 部分。
J Comp Eff Res. 2023 Jul;12(7):e230092. doi: 10.57264/cer-2023-0092. Epub 2023 Jun 22.
8
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10.我们是否已经准备好进行报销了？关于与健康技术评估相关的真实世界证据的最新进展综述：第 10 部分。
J Comp Eff Res. 2023 Jan;12(1):e220194. doi: 10.2217/cer-2022-0194. Epub 2022 Dec 1.
9
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 9.我们是否已经准备好进行报销了？关于与健康技术评估相关的真实世界证据的最新进展综述：第 9 部分。
J Comp Eff Res. 2022 Nov;11(16):1147-1149. doi: 10.2217/cer-2022-0145. Epub 2022 Aug 23.
10
Machine Learning Methods in Health Economics and Outcomes Research-The PALISADE Checklist: A Good Practices Report of an ISPOR Task Force.机器学习方法在健康经济学和结果研究中的应用-PALISADE 清单：ISPOR 工作组的良好实践报告。
Value Health. 2022 Jul;25(7):1063-1080. doi: 10.1016/j.jval.2022.03.022.

我们准备好申请报销了吗？健康技术评估相关真实世界证据的发展综述：第15部分。

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 15.

作者信息

Castanon Alejandra, Bray Benjamin D, Ramagopalan Sreeram V

机构信息

Lane Clark & Peacock LLP, London, W1U 1DQ, UK.

Department of Population Health Sciences, King's College London, SE1 9NH, UK.

出版信息

J Comp Eff Res. 2024 May;13(5):e240033. doi: 10.57264/cer-2024-0033. Epub 2024 Mar 28.

DOI:10.57264/cer-2024-0033
PMID:38546012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11037032/
Abstract

In this latest update we discuss real-world evidence (RWE) guidance from the leading oncology professional societies, the American Society of Clinical Oncology and the European Society for Medical Oncology, and the PRINCIPLED practical guide on the design and analysis of causal RWE studies.

摘要

在此次最新更新中，我们讨论了来自领先肿瘤学专业协会——美国临床肿瘤学会和欧洲医学肿瘤学会的真实世界证据（RWE）指南，以及关于因果性RWE研究设计与分析的PRINCIPLED实用指南。